News

DSN resident PharmD takes over @DrugStoreNews for global #Pharmacist ‘tweet-a-thon’

BY Rob Eder

NEW YORK — Drug Store News director of continuing education and clinical content Suzanne Feeney, PharmD, will take over the Drug Store News twitter handle @drugstorenews, as part of the global #Pharmacist tweet-a-thon on Thursday, Oct. 2. 
 
Highlighting the important role pharmacists have in patient care, their communities and the healthcare industry at-large, the annual event, now in its second year, pharmacists from all over the world will tweet about what they have done to help advance community pharmacy practice. Last year, more than 7,100 tweets with the hashtag #Pharmacist were sent during the inaugural event, noted the Community Pharmacy Association, with #Pharmacist ranking as the highest trending healthcare-related hashtag that day, Oct. 3, 2013.
 
Feeney, a former Supervalu pharmacist, and coordinator of the Drug Store News Continuing Education program, will lead the conversation for DSN during the one-day pharmacist tweet-a-thon. 
 
What is your company doing to help advance the role of community pharmacy in health care, and/or helping to advance the practice of pharmacy at retail? Join the conversation on Oct. 2 — and don’t forget to use the hashtag #Pharmacist.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

C&S Wholesale Grocers names SVP, independent sales

BY Antoinette Alexander

KEENE, N.H. — C&S Wholesale Grocers has appointed Christopher Brown as SVP, independent sales, effective Sept. 29, underscoring its commitment to independent customers and reflecting its plans to continue to grow the independent business.

Brown has spent his career in executive leadership roles in the distribution and supply chain industry, servicing independent retailers and regional chains. Most recently he served as an executive consultant working with national distributors and regional retailers. Prior to that, he spent 11 years with Nash Finch Co., serving as EVP, procurement/merchandising and EVP, food distribution, before being named president/COO.

“Christopher is joining C&S at a time when we are putting immense focus on our independent business,” said Rick Cohen, C&S chairman and CEO. “His expertise about the unique requirements of independent retailers will be a perfect complement to the strong service we already provide to our independent, chain, and large grocer customers.”

C&S Wholesale Grocers currently supplies 5,000 independent supermarkets, chain stores, military bases and institutions with more than 150,000 different products.

In a separate announcement, C&S Wholesale Grocers also announced the appointment of Alejandro Rodriguez Bas as EVP, new business and market development, effective Sept. 29.

Rodriguez was most recently CEO of Grupo LALA, the largest dairy company in Latin America, and he previously spent nearly 10 years with PepsiCo in executive leadership positions in Mexico, Central America, the Caribbean, Australia and New Zealand.
 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Boehringer Ingelheim’s Spiriva Respimat approved for COPD treatment

BY Ryan Chavis

RIDGEFIELD, Conn. — Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration approved Spiriva Respimat (tiotropium bromide) inhalation spray as a treatment for bronchospasm associated with chronic obstructive pulmonary disease. The company anticipates the spray to be available in January 2015. 
 
Spiriva Respimat provides the user with a pre-measured amount of medication in a slow-moving mist, helping patients to inhale the medicine. It was developed to deliver medication in a way that doesn't depend on how fast air is taken in from the inhaler. 
 
"Spiriva Respimat offers a new choice between a mist and dry powder inhaler for tiotropium," said Sabine Luik, M.D., SVP, medicine and regulatory affairs, Boehringer Ingelheim Pharmaceuticals. "Already approved in 85 countries around the world, Spiriva Respimat reflects our scientific heritage as an industry leader in discovering and developing new treatment options for the COPD community."
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?